| 238.60 Real-Time Quote | -4.16 / -1.71%Today’s Change | 107.31 Today|||52-Week Range 283.99 | +39.48% Year-to-Date |
| Today's 3 Best Stocks Jun 18 / MotleyFool.com | Valeant Biting More Than it Can Chew Jun 13 / MotleyFool.com |
| Jefferies Says Analysis on Elan Supports $19/Share Takeover Bid, Lifts Price Target t... Jun 18 / Benzinga | Does This Pipeline Promise Tomorrow's Blockbuster Sales? Jun 12 / MotleyFool.com |
| Top Treatments for High Cholesterol Jun 17 / MotleyFool.com | The First Real Cure in the $25 billion Asthma Market? Jun 12 / MotleyFool.com |
| Is This Eye Drug Worth The Hype? Jun 17 / MotleyFool.com | Positive Data on Bayer/REGN's Eye Drug - Analyst Blog Jun 07 / Zacks.com |
| Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Health Care Laggard Jun 14 / TheStreet.com | Today's 3 Best Stocks Jun 06 / MotleyFool.com |
| Is This Eye Drug Worth The Hype? Jun 14 / MotleyFool.com |